B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
Figure 2
Serum BAFF concentrations of (a, b) (before treatment, at 6 months after the start of therapy) and healthy control subjects. was statistically significant.